The Guardian Hemostasis Valve exhibits the successful implementation of Zerusa's progressive business model. Guardian was developed through a collaborative partnership with a successful cardiologist and is designed to be the next generation hemostasis valve for all interventional procedures. More >>

Why We

Are Different

Our strength lies in developing close partnerships with our physician inventors, entrepreneurs or partner companies to identify and exploit an unmet need in the market. We work the front lines with the physicians in coronary cath labs, peripheral radiology labs and neuroradiology labs to understand physician needs, challenges and opportunities. We have the capability to realize those product improvements or new product ideas that larger medical device companies overlook. Yet, we are willing to work with those same companies to market our innovative technologies.

Product

Development Cycle

We leverage our collective knowledge and experience to support the research, development and distribution of our products. We are building value in the company by developing innovative, products which are unique, intellectual property based and address an unmet need in the market.

Recent News & Events

October 12 , 2009

Zerusa Limited and Vascular Solutions Announce FDA Market Clearance for the Next Generation Guardian II Hemostasis Valve

September 30, 2009

Rollout for CE marked Guardian II begins

July 28, 2009

Zerusa Limited to attend MedinIreland exhibition in Dublin on October 20, 2009